Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
RAPT Therapeutics ( (RAPT) ) has provided an announcement.
On March 21, 2025, Dr. Wendye R. Robbins informed RAPT Therapeutics’ Board of Directors that she will not seek re-election at the company’s 2025 annual meeting, marking the end of her tenure. Subsequently, on March 25, 2025, the Board decided to reduce its size from six to five members, effective at the annual meeting.
More about RAPT Therapeutics
YTD Price Performance: -11.04%
Average Trading Volume: 956,467
Technical Sentiment Signal: Buy
Current Market Cap: $191.4M
For a thorough assessment of RAPT stock, go to TipRanks’ Stock Analysis page.